Not a good buy right now: the stock is in a clear short-term downtrend (bearish moving averages + worsening MACD) after a sharp -12.29% regular-session drop.
Even though the stock is very oversold short-term (RSI_6 ~21) and could bounce, the trend/structure suggests downside risk still dominates until price stabilizes above nearby resistance.
With no Intellectia buy signals today and no fresh news catalyst, the risk/reward is not attractive for an impatient buyer right now.
Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating price is trending down across short/medium/long windows.
Momentum: MACD histogram -0.238 and negatively expanding → bearish momentum is strengthening.
RSI: RSI_6 at 21.09 signals deeply oversold conditions (bounce potential), but oversold alone is not a trend reversal.
Key levels: Price ~17.73 is below S1 (18.055), implying a breakdown of a near support; next support is S2 at 16.575. Overhead pivot/resistance sits far higher (Pivot 20.45; R1 22.845).
Pattern-based forecast: Similar-pattern stats imply ~-1.8% over the next week, despite a modest +3.12% next-month probability—suggesting near-term pressure first.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Put/Call open interest ratio 0.35 and volume put/call ratio 0.03 are strongly call-skewed (bullish tilt).
Caveat: Absolute volume is tiny (calls 105 vs puts 3; total 108) and far below recent averages (5D avg ~944.6), so today’s options flow may not be very informative.
Volatility: 30D IV 48.65 vs historical vol 40.44 (IV > HV) → options are pricing elevated uncertainty.
IV trend: IV 5D avg 67.4 and 10D avg 63.18 are higher than current 30D IV reading shown, implying volatility has recently been elevated and may be coming down from higher levels.
Technical Summary
Sell
9
Buy
4
Positive Catalysts
Oversold technical condition (RSI_6 ~
can fuel a reflex bounce if selling pressure eases.
Neutral/Negative Catalysts
raises risk of a move toward S2 (16.575).
can be a downside catalyst if guidance or margins disappoint.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $112.95M, up 31.49% YoY (strong growth).
Earnings/profitability: Net income improved to -$14.80M (56.79% improvement YoY) and EPS improved to -0.14 (up 55.56% YoY), but still loss-making.
Margin: Gross margin 55.28%, down 5.50% YoY, a notable deterioration to monitor (mix/price/cost pressures).
Overall: Growth is strong, losses are narrowing, but margin compression is a key negative trend.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent change: 2026-01-16 Stephens cut price target to $28 from $31, maintained Overweight.
What it signals: Street view remains broadly constructive on the company/space, but expectations were trimmed (less upside vs prior).
Wall Street pros: Strong revenue growth profile; sector sentiment expected to improve into 2026.
Wall Street cons: Ongoing losses and margin compression; recent volatility/price breakdown can keep multiples and sentiment pressured short-term.
Influential/political trading: No recent congress trading data available; hedge funds and insiders are neutral with no significant recent trend.
Wall Street analysts forecast ALKT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALKT is 32.5 USD with a low forecast of 25 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast ALKT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALKT is 32.5 USD with a low forecast of 25 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 16.840
Low
25
Averages
32.5
High
40
Current: 16.840
Low
25
Averages
32.5
High
40
Stephens
Stephens
Overweight
downgrade
$31 -> $28
AI Analysis
2026-01-16
Reason
Stephens
Stephens
Price Target
$31 -> $28
AI Analysis
2026-01-16
downgrade
Overweight
Reason
Stephens lowered the firm's price target on Alkami to $28 from $31 and keeps an Overweight rating on the shares as part of the firm's 2026 outlook note for the Financial Technology group. After a challenging 2025, the firm expects sentiment towards the Payment and IT Services space to improve in the coming year, the analyst tells investors.
Goldman Sachs
Adam Hotchkiss
Neutral
downgrade
$29 -> $26
2025-11-03
Reason
Goldman Sachs
Adam Hotchkiss
Price Target
$29 -> $26
2025-11-03
downgrade
Neutral
Reason
Goldman Sachs analyst Adam Hotchkiss lowered the firm's price target on Alkami to $26 from $29 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ALKT